Mass Reclassification Possible For Remaining Transitional Devices
This article was originally published in The Gray Sheet
Executive Summary
An omnidisciplinary panel of experts to review transitional devices is one option being considered by FDA as a strategy for the mass reclassification of the products, agency officials indicate.